← All trials
NCT06396078
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 18, 2024
- Primary completion
- Aug 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- May 2, 2024
- Last posted
- Jul 29, 2024
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ohio State UniversityLead sponsor
- Ohio State UniversitySponsor investigator
- Ohio State UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.